Physician profile
Eugene Buchwald
NPI 1588724777
$1,083.55
in general payments reported to CMS, 2019-2025
31 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $714 · 2020: $271 · 2021: $28.62 · 2022: $33.58 · 2023: $36.31.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $36.31.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $36.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Emd Serono, INC. | $120.51 | 2019-2020 | |
| Biogen, INC. | $103.28 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $69.89 | 2019 | |
| Alexion Pharmaceuticals, INC. | $59.62 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $49.82 | 2019 | |
| Mallinckrodt Enterprises LLC | $47.73 | 2019 | |
| Amgen INC. | $47.54 | 2019 | |
| Ucb, INC. | $43.60 | 2019-2020 | |
| Kyowa Kirin, INC. | $42.52 | 2020-2021 | |
| Avanir Pharmaceuticals, INC. | $40.28 | 2019-2020 | |
| Allergan, INC. | $39.95 | 2019-2020 | |
| Boston Scientific Corporation | $36.31 | 2023 | |
| Celgene Corporation | $33.58 | 2022 | |
| Akcea Therapeutics, INC. | $30.47 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $29.14 | 2019-2020 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $28.63 | 2019-2020 | |
| Supernus Pharmaceuticals, INC. | $28.40 | 2019 | |
| Acadia Pharmaceuticals INC | $26.83 | 2019 | |
| Lilly USA, LLC | $25.78 | 2019-2020 | |
| Aprecia Pharmaceuticals, LLC | $23.53 | 2019-2020 | |
| Adamas Pharmaceuticals, INC. | $14.95 | 2020 | |
| Neurocrine Biosciences, INC. | $14.93 | 2019 | |
| Janssen Pharmaceuticals, INC | $14.93 | 2019 | |
| Acorda Therapeutics, INC | $14.81 | 2019 | |
| Jazz Pharmaceuticals INC. | $14.69 | 2019 | |
| Grifols USA, LLC | $14.43 | 2019 | |
| Amneal Pharmaceuticals LLC | $14.09 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $14.03 | 2020 | |
| Ge Healthcare | $13.82 | 2021 | |
| Currax Pharmaceuticals LLC | $13.01 | 2020 | |
| Eisai INC. | $12.45 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eugene Buchwald listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.